Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy. | Cancer Manag Res | 2022 | 35720644 | PubTator, text mining | PubMed |
| The power of heteronemin in cancers. | J Biomed Sci | 2022 | 35705962 | PubTator, text mining | PubMed |
| Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis. | Front Oncol | 2022 | 35692797 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone. | Comput Struct Biotechnol J | 2022 | 35685372 | PubTator, text mining | PubMed |
| A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease. | Kidney Int Rep | 2022 | 35685307 | PubTator, text mining | PubMed |
| The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer. | BMC Cancer | 2022 | 35681118 | PubTator, text mining | PubMed |
| SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases. | Front Oncol | 2022 | 35669422 | PubTator, text mining | PubMed |
| Interactions between EGFR and EphA2 promote tumorigenesis through the action of Ephexin1. | Cell Death Dis | 2022 | 35668076 | PubTator, text mining | PubMed |
| Decoding a gene expression program that accompanies the phenotype of sporadic and basal cell nevus syndrome-associated odontogenic keratocyst. | J Oral Pathol Med | 2022 | 35665542 | PubTator, text mining | PubMed |
| Sleep Disruption and Cancer: Chicken or the Egg? | Front Neurosci | 2022 | 35663547 | PubTator, text mining | PubMed |
| DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma. | Acta Neuropathol | 2022 | 35660939 | PubTator, text mining | PubMed |
| EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance. | World J Gastrointest Oncol | 2022 | 35646281 | PubTator, text mining | PubMed |
| Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma. | Front Genet | 2022 | 35646067 | PubTator, text mining | PubMed |
| Investigating the Association Between Polygenic Risk Scores for Alzheimer's Disease With Cognitive Performance and Intrinsic Functional Connectivity in Healthy Adults. | Front Aging Neurosci | 2022 | 35645768 | PubTator, text mining | PubMed |
| EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia. | Diagnostics (Basel) | 2022 | 35626181 | PubTator, text mining | PubMed |
| The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer. | Front Endocrinol (Lausanne) | 2022 | 35620395 | PubTator, text mining | PubMed |
| Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies. | PLoS One | 2022 | 35617355 | PubTator, text mining | PubMed |
| The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure. | Front Cell Neurosci | 2022 | 35614970 | PubTator, text mining | PubMed |
| Cellular and molecular mechanisms of EPH/EPHRIN signaling in evolution and development. | Curr Top Dev Biol | 2022 | 35606056 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=25